BCRX
BioCrystBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
BCRX vs peer average
79/100
BCRX vs. peer average (B vs. D)
Grade spread
C 4 · D 4 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
DNTH is the first available peer comparator.
Dianthus is a looser small-cap rare-disease comparator from the packet rather than a clean HAE operating comp, but it is still useful for framing valuation sensitivity around milestone-driven biotech programs.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
BCRX
BioCryst
DNTH
Dianthus Therapeutics
Grade
B
B
Momentum
52
92
Value
61
41
Sentiment
72
50
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs DNTH
BCRX / DNTH
Grade Position
Above peers
BCRX vs. peer average (B vs. D)
79/100
Momentum
52
DNTHValue
61
BCRXSentiment
72
BCRXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs BCRX
DNTH is the first peer returned for this comparison set.